Business Context and Reporting Period
This Form 8-K was filed by AmerisourceBergen Corporation (now Cencora, Inc.) on November 9, 2022. The report discloses corporate governance changes, specifically the election of a new director to the Board of Directors.
Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on personnel appointments and compensation arrangements.
Material Changes
The primary material change reported is the election of Redonda G. Miller, M.D., to the Board of Directors, effective January 1, 2023. Dr. Miller brings significant healthcare leadership experience, having served as President of The Johns Hopkins Hospital since 2016.
Guidance, Outlook, and Management Commentary
There is no financial guidance, outlook, or management commentary regarding business operations in this filing. The Board determined Dr. Miller to be an independent director under NYSE standards. Her compensation package includes an annual cash retainer of $100,000 and an annual equity award valued at $200,000 on the grant date. No related party transactions requiring disclosure were identified.
Key Facts for Investor Verification
- Redonda G. Miller, M.D., was elected to the Board effective January 1, 2023.
- Dr. Miller is considered an independent director.
- Annual compensation for the new director is set at $100,000 cash and $200,000 in equity.
- The filing contains no financial results or operational updates.